PRADAXA Boehringer Ingelheim

192,00 

SKU: EU22253 Categories: ,

Additional information

Active substance

Dabigatran

Formula

C34H41N7O5

Side effects

Bleeding, gastrointestinal upset, heartburn, nausea

Effects

Reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation

Dosage (sports)

Not applicable as it is not used for sports enhancement

Dosage (medical)

150 mg or 110 mg twice daily depending on renal function

Half-life

12 to 17 hours

Main action

Anticoagulant

Substance class

Direct thrombin inhibitor

Chemical name

N-{2-[4-(N'-{[(Hexyloxy)carbonyl]carbamimidoyl}carbamimidoyl)phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl}-N-pyridin-2-yl-beta-alanine ethyl ester

Storage conditions

Store at room temperature away from moisture and heat

FORM

60 caps x 75 mg

Trade name

Pradaxa

Blood pressure

Typically does not affect blood pressure

Also known as

Dabigatran

Lab Test

Monitoring of renal function and possibly coagulation parameters

Hepatotoxicity

No significant hepatotoxicity

Water Retention

No significant water retention

Use in sports

None, as it does not enhance athletic performance

Manufacturer

Boehringer

Reviews

There are no reviews yet.

Be the first to review “PRADAXA Boehringer Ingelheim”

Your email address will not be published. Required fields are marked *